Literature DB >> 30692851

Immunopathological Factors Associated with Disability in Multiple Sclerosis.

Erdem Tüzün1.   

Abstract

In multiple sclerosis (MS), disability occurs as a result of complex interactions between glial cells and diverse components of acquired immunity. Microglial cells significantly contribute to disability progression by re-activating infiltrating lymphocytes, releasing neuro- and oligodendrocytotoxic mediators, inducing oxidative stress, and interfering with neuroplasticity. Recent research has emphasized the significance of meningeal B cell infiltrates in development of cognitive decline and disability. B cells are also involved in disability progression by way of production of neurotoxic antibodies directed against axoglial antigens. Among several immunological factors, neurofilament light chain antibodies, IgM-type oligoclonal bands, complement factor C3, and microglia-derived mediators stick out as potential reliable predictors of disability progression in MS patients. Better understanding of the interactions between innate immunity and neuroaxonal degeneration may result in development of novel and effective therapeutics for progressive types of MS.

Entities:  

Keywords:  Multiple sclerosis; antibody; cytokine; disability; microglia

Year:  2018        PMID: 30692851      PMCID: PMC6278616          DOI: 10.29399/npa.23303

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  50 in total

Review 1.  Multiple sclerosis--the plaque and its pathogenesis.

Authors:  Elliot M Frohman; Michael K Racke; Cedric S Raine
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

2.  Kynurenine metabolism in multiple sclerosis.

Authors:  Z Hartai; P Klivenyi; T Janaky; B Penke; L Dux; L Vecsei
Journal:  Acta Neurol Scand       Date:  2005-08       Impact factor: 3.209

3.  Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis.

Authors:  R Ehling; A Lutterotti; J Wanschitz; M Khalil; C Gneiss; F Deisenhammer; M Reindl; T Berger
Journal:  Mult Scler       Date:  2004-12       Impact factor: 6.312

4.  Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors.

Authors:  Eduard Urich; Ilona Gutcher; Marco Prinz; Burkhard Becher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-22       Impact factor: 11.205

5.  Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport.

Authors:  Hideyuki Takeuchi; Tetsuya Mizuno; Guiqin Zhang; Jinyan Wang; Jun Kawanokuchi; Reiko Kuno; Akio Suzumura
Journal:  J Biol Chem       Date:  2005-01-07       Impact factor: 5.157

6.  Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan.

Authors:  Peter H Larsen; Jennifer E Wells; William B Stallcup; Ghislain Opdenakker; V Wee Yong
Journal:  J Neurosci       Date:  2003-12-03       Impact factor: 6.167

Review 7.  IDO expression in the brain: a double-edged sword.

Authors:  Erik Kwidzinski; Ingo Bechmann
Journal:  J Mol Med (Berl)       Date:  2007-06-27       Impact factor: 4.599

8.  Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.

Authors:  Massimiliano Calabrese; Federica Agosta; Francesca Rinaldi; Irene Mattisi; Paola Grossi; Alice Favaretto; Matteo Atzori; Valentina Bernardi; Luigi Barachino; Luciano Rinaldi; Paola Perini; Paolo Gallo; Massimo Filippi
Journal:  Arch Neurol       Date:  2009-09

Review 9.  Astrocytes--friends or foes in multiple sclerosis?

Authors:  Anna Williams; Gabrièle Piaton; Catherine Lubetzki
Journal:  Glia       Date:  2007-10       Impact factor: 7.452

10.  Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.

Authors:  C Wegner; M M Esiri; S A Chance; J Palace; P M Matthews
Journal:  Neurology       Date:  2006-09-26       Impact factor: 9.910

View more
  2 in total

1.  IL27 T4730C Polymorphism and Serology in Multiple Sclerosis: A Pilot Study.

Authors:  Ioana S Barac; Vitalie Văcăraș; Angela Cozma; Mădălina Văleanu; Nicoleta Decea; Dafin F Mureșanu; Lucia M Procopciuc
Journal:  In Vivo       Date:  2021 Sep-Oct       Impact factor: 2.155

2.  Potential Contribution of IL-27 and IL-23 Gene Polymorphisms to Multiple Sclerosis Susceptibility: An Association Analysis at Genotype and Haplotype Level.

Authors:  Ioana S Barac; Mihaela Iancu; Vitalie Văcăraș; Angela Cozma; Vasile Negrean; Dorel Sâmpelean; Dafin F Mureșanu; Lucia M Procopciuc
Journal:  J Clin Med       Date:  2021-12-22       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.